Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the study's record history, and the previous revision, v3.6.2, was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-04T14:43:14.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry for v3.6.2, following the previous v3.6.0 entry, signaling an administrative update to the record.
    Difference
    0.1%
    Check dated 2026-06-27T13:45:44.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The record history adds the Last verified and Last known status was fields. It also updates the revision label to v3.6.0, replacing v3.5.5.
    Difference
    3%
    Check dated 2026-06-13T16:49:06.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.5) was added to the record history, replacing the previous revision (v3.5.4).
    Difference
    0.1%
    Check dated 2026-06-06T17:15:12.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new revision entry is added to the record history (v3.5.4) replacing the previous revision (v3.5.3). This reflects an updated version of the page metadata rather than substantive changes to the trial data.
    Difference
    0.1%
    Check dated 2026-05-16T10:10:40.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from v3.5.0 to v3.5.3. This reflects a change to the site’s versioning rather than any updates to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-25T05:24:48.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.